A. Sayiner (Izmir, Turkey), N. Stanton (Cardiff, United Kingdom), P. Mallia (London, United Kingdom)
Late-breaking abstract: When is pleural fluid microbiology useful?
K. Woolnough, I. Hussain (Stoke-on-Trent, United Kingdom)
|   |
Late-breaking abstract: Inhaled calcium based dry powder inhibits rhinovirus-induced inflammation and exacerbation in a mouse model of allergic airway inflammation
P. Wright Andreotta, S. Kong, T. Brogan, S. Arold, P. Okerholm, F. Saia, R. Clarke, D. Hava (Lexington, United States Of America)
| |
Late-breaking abstract: Prevalence of influenza A H1N1 virus infection in patients with asthmatic crisis of the National Institute of Respiratory Diseases (in Mexico City)
O. Sánchez Cabral, J. Rodríguez Barragán, M. D. J. Castillejos López (Mexico, Mexico)
| |
Macrolide therapy is associated with lower 30-day mortality in patients with non-pneumonia and pneumonia severe sepsis
M. Restrepo, E. Mortensen, L. Copeland, B. Nakashima, M. Pugh, A. Anzueto (San Antonio, Temple, United States Of America)
| |
Antimicrobial resistance genotype trends and association with host clinical characteristics in respiratory isolates of haemophilus influenzae
E. Hagiwara, N. Tsuchiya, T. Enomoto, T. Baba, T. Shinohara, R. Nishihira, S. Komatsu, T. Kato, T. Ogura, H. Takahashi (Yokohama, Japan)
| |
Prior outpatient antibiotic use in patients with community acquired pneumonia (CAP) admitted in hospital
C. Senent, E. Chiner, J. N. Sancho-Chust, A. Cervera, E. Fernández-Fabrellas, J. Blanquer, F. Sanz, M. del Carmen Aguar (San Juan, Valencia, Castellón, Spain)
| |
Clinical outcomes of tigecycline in the treatment of critically ill patients with multidrug-resistant Acinetobactor baumannii infection
J. A. Shin, H. J. Kim, M. K. Byun (Seoul, Republic Of Korea)
| |
Randomised controlled trial of sequential intravenous and oral azithromycin compared with intravenous ceftriaxone followed by cefixime both in combination with clarithromycin in hospitalized patients with community-acquired pneumonia
A. Etemadi, A. Ardeshirzadeh, M. Maaleki, A. Chenaneh, S. Ahmadi (Ahvaz, Islamic Republic Of Iran)
| |
Effectiveness of once daily meropenem for the treatment of aspiration pneumonia of elderly patients in long-term care facilities
A. Etemadi, P. Salehi, K. Etemadi (Ahvaz, Islamic Republic Of Iran)
| |
Potential protective role of prior to diagnosis antibiotic treatment in community-acquired pneumonia: Clinical presentation and outcomes
F. Sanz, E. Fernández, A. Cervera, M. C. Aguar, M. Briones, E. Chiner, C. Senent, J. Sancho, J. Blanquer (Valencia, Spain)
| |
Antibiotic prescription patterns in hospitalized patients with community-acquired pneumonia in local hospital: 10 year follow-up
A. Vizel, G. Lysenko (Kazan, Russian Federation)
| |
Clinical efficacy of bolus versus continuous-infusion of piperacillin-tazobactam in VAP treatment
S. Ziaie, F. Fahimi, H. R. Jamaati, P. Tabarsi, S. M. R. Hashemian, S. Ghafari, S. Bani Asadi (Tehran, Islamic Republic Of Iran)
| |
Difference of patient background with pneumonia between monotherapy and combination
M. Shibasaki, M. Nishikawa, Y. Kitagawa, K. Senda, K. Nakashima, F. Mizokami (Oobu, Japan)
| |
Auditing patterns of azithromycin use in respiratory disease
D. Hodgson, R. Hurford, T. Harrison, D. Shaw (Nottingham, United Kingdom)
| |
PcrV antibody prophylaxis in combination with antibiotic therapy reduces lung injury and improves survival in pseudomonas aeruginosa infected mice
Y. Song, M. Baer, R. Srinivasan, J. Lima, G. Yarranton, C. Bebbington, S. Lynch (Shanghai, China; San Francisco, United States Of America)
| |
Are multi-drug resistant (MDR) pathogens related to higher mortality in pneumonia?
S. Seghezzi, M. Di Pasquale, S. Aliberti, G. Marullo, V. Monzani, A. M. Brambilla, R. Cosentini (Milan, Monza, Italy)
| |
Implementation of severity guided antibiotic treatment according to Dutch guidelines in hospitalized patients with community-acquired pneumonia (CAP) included in a clinical trial
D. Snijders, C. de Graaff, T. van der Werf, W. Boersma (Alkmaar, Groningen, Netherlands)
| |
Effect of benzylpenicillin-ciprofloxacin vs. ceftriaxon-ciprofloxacin in treatment of massive pneumonia (CAP-community acquired pneumonia)
V. Radosavljevic, M. Obradovic, N. Petrovic (Belgrade, Republic Of Serbia)
| |